HUTCHMED (China) Ltd
Develops and commercializes targeted therapies for cancer and immunological diseases worldwide.
HCM | NDAQ
Overview
Corporate Details
- ISIN(s):
 - N/A
 - LEI:
 - Country:
 - United States of America
 - Address:
 - 48TH FLOOR, CHEUNG KONG CENTER, 0 HONG KONG
 - Website:
 - https://www.hutch-med.com/
 - Sector:
 - Manufacturing
 - Industry:
 - Manufacture of pharmaceuticals, medicinal chemical and botanical products
 
Description
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery, global development, and commercialization of targeted therapies and immunotherapies. The company focuses on treating cancer and immunological diseases through a science-driven approach, developing highly selective and potent therapies engineered to improve drug exposure and reduce off-target toxicities. Its in-house discovery engine has produced over 20 novel drug candidates, with several products approved and marketed in China, the US, the EU, and Japan. HUTCHMED maintains a robust global pipeline, conducting numerous clinical trials worldwide to address unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all HUTCHMED (China) Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HUTCHMED (China) Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HUTCHMED (China) Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||